Research & Development



  唯一不夠的地方就在于勒石燕然這件事,陛下一日不封禪泰山,勒石燕然就輝煌的讓人無法忘記。   基本上,只要是上了科考場的人,都自認為皇帝門生,他們驕傲的認為,自己可以走正途,沒必要討好後宮的貴人來為自己謀一份好的差事。大香蕉网伊人在线   霍去病抓著曹襄的肩膀就把他從籃筐里提出來,頓在地上道︰“你連秋千架都不敢上,誰敢指望你上天。”色天使论坛最新地址   阿嬌有目的的把藍田送去了皇宮,希望她能與自己的兄弟姐妹們相處一下。   雲瑯搖頭道︰“沒有誰是神,即便這世上真的有神靈存在,他也會感到疑惑。畢竟,面對的是一個個活生生的人,總有變化的。”私色房综合网影视   看顧劉的宮娥快要嚇死了,含著眼淚不敢叫喚,只能緊緊跟隨,不敢怠慢。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo